We demonstrated that CD137/CD137L activation signaling promoted the activation and proliferation of tumor-specific T cells, increased the secretion of cytokines, and protected T cells from activation-induced cell death [28, 29]. The gene discussed is TNFRSF9; the disease is neoplasm.